Memantine Grindeks

Memantine Hydrochloride, the active ingredient in Memantine Grindeks, is an NMDA receptor antagonist presented as an oral tablet for oral use. It is employed in the management of Alzheimer’s disease, helping to mitigate cognitive decline and functional impairment in adult patients.

GNH USA supplies Memantine Grindeks as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company ensures quality and regulatory compliance across markets, providing reliable access to essential medicines. This is achieved through a robust supply chain and validated manufacturing processes.

Memantine Hydrochloride is indicated for neurodegenerative conditions where excessive NMDA receptor activity contributes to neuronal damage. - Alzheimer's disease (mild to moderate): improves cognition and daily functioning in affected adults. - Alzheimer's disease (moderate to severe): helps maintain activities of daily living and may slow functional decline. - Behavioral symptoms of Alzheimer’s disease: may reduce agitation and aggression associated with the condition.

Memantine Hydrochloride may be associated with several adverse reactions, ranging from mild to severe.

Common Side Effects: - Dizziness - Headache - Constipation - Fatigue - Confusion - Hypertension

Serious or Rare Side Effects: - Seizures - Severe allergic reactions (e.g., rash, angioedema) - Hepatic dysfunction - Stevens‑Johnson syndrome or toxic epidermal necrolysis - Suicidal thoughts or behavior - Cardiac arrhythmias

When prescribing Memantine Hydrochloride, clinicians should consider several safety aspects to minimize risk. - Renal impairment: adjust dose and monitor renal function regularly. - Hepatic impairment: use with caution and assess liver enzymes periodically. - History of seizures: evaluate risk and monitor for seizure activity. - Concomitant NMDA antagonists: avoid combined use to prevent additive neurotoxicity. - Pregnancy: potential risk unknown; use only if benefits outweigh risks. - Store at ambient temperature: keep in original packaging, protect from moisture and light.

Memantine Hydrochloride can interact with other medicines, influencing its efficacy or safety.

Major Interactions (Avoid): - Amantadine: increased risk of neurotoxic effects when combined. - Other NMDA receptor antagonists: additive inhibition may lead to excessive CNS depression. - Strong CYP3A4 inducers (e.g., rifampin, carbamazepine): may reduce memantine plasma concentrations.

Moderate Interactions (Monitor Closely): - Antihypertensive agents: memantine may enhance hypotensive response. - Anticholinergic drugs: may diminish cognitive benefits of memantine. - Diuretics: increased risk of dizziness or orthostatic hypotension.